IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 127 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $454 | -35.4% | 100,000 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $703 | +15.2% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $610 | -3.0% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $629 | -99.9% | 100,000 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $942,000 | -29.3% | 100,000 | -19.3% | 0.00% | -25.0% |
| Q2 2022 | $1,333,000 | -35.6% | 123,900 | 0.0% | 0.00% | -20.0% |
| Q1 2022 | $2,069,000 | -4.7% | 123,900 | +10.0% | 0.01% | 0.0% |
| Q4 2021 | $2,171,000 | -28.9% | 112,600 | -11.8% | 0.01% | -44.4% |
| Q3 2021 | $3,055,000 | -8.6% | 127,600 | 0.0% | 0.01% | -10.0% |
| Q2 2021 | $3,343,000 | +77.5% | 127,600 | +100.6% | 0.01% | +66.7% |
| Q1 2021 | $1,883,000 | -38.3% | 63,600 | 0.0% | 0.01% | -45.5% |
| Q4 2020 | $3,054,000 | +241.6% | 63,600 | +128.8% | 0.01% | +175.0% |
| Q3 2020 | $894,000 | -63.7% | 27,800 | -74.5% | 0.00% | -66.7% |
| Q2 2019 | $2,462,000 | +54.9% | 109,000 | +21.1% | 0.01% | +33.3% |
| Q1 2019 | $1,589,000 | +451.7% | 90,000 | +176.9% | 0.01% | +350.0% |
| Q4 2018 | $288,000 | -81.9% | 32,500 | -63.9% | 0.00% | -77.8% |
| Q3 2018 | $1,589,000 | +32.7% | 90,000 | -2.6% | 0.01% | +12.5% |
| Q2 2018 | $1,197,000 | +71.0% | 92,400 | +117.9% | 0.01% | +60.0% |
| Q1 2018 | $700,000 | – | 42,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |